Rasmus Jansson‐Löfmark

Robust anti‐obesity and metabolic effects of a dual <scp>GLP</scp> ‐1/glucagon receptor peptide agonist in rodents and non‐human primates

Susan Henderson, Anish Konkar, David C. Hornigold et al. · Diabetes Obesity and Metabolism · 2016 · 235 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Targeted delivery of antisense oligonucleotides to pancreatic β-cells

Carina Ämmälä, William J. Drury, Laurent Knerr et al. · Science Advances · 2018 · 187 citations · Full text

Pharmacy, Endocrinology, Pharmaceutics +16

An oral antisense oligonucleotide for PCSK9 inhibition

Peter Gennemark, Katrin Walter, Niclas Clemmensen et al. · Science Translational Medicine · 2021 · 121 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell

Laurent Knerr, Thazha P. Prakash, Richard Lee et al. · Journal of the American Chemical Society · 2021 · 75 citations

Pharmacy, Endocrinology, Pharmacology +17

Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion

Krister Bamberg, Ulrika Johansson, K. A. P. Edman et al. · PLoS ONE · 2018 · 74 citations · Full text

Medicine, Cardiology, Pharmacology +14